Journal Article

Altered Env conformational dynamics as a mechanism of resistance to peptide-triazole HIV-1 inactivators

Zhang, Shiyu, Canziani, Gabriela A., Dick, Alexej, Root, Michael J., Enríquez Rodríguez, Lucía, Holmes, Andrew P., Rashad, Adel A., Chaiken, Irwin M.

2021

Overview

Background We previously developed drug-like peptide triazoles (PTs) that target HIV-1 Envelope (Env) gp120, potently inhibit viral entry, and irreversibly inactivate virions. Here, we investigated potential mechanisms of viral escape from this promising class of HIV-1 entry inhibitors. Results HIV-1 resistance to cyclic (AAR029b) and linear (KR13) PTs was obtained by dose escalation in viral passaging experiments. High-level resistance for both inhibitors developed slowly (relative to escape from gp41-targeted C-peptide inhibitor C37) by acquiring mutations in gp120 both within (Val255) and distant to (Ser143) the putative PT binding site. The similarity in the resistance profiles for AAR029b and KR13 suggests that the shared IXW pharmacophore provided the primary pressure for HIV-1 escape. In single-round infectivity studies employing recombinant virus, V255I/S143N double escape mutants reduced PT antiviral potency by 150- to 3900-fold. Curiously, the combined mutations had a much smaller impact on PT binding affinity for monomeric gp120 (four to ninefold). This binding disruption was entirely due to the V255I mutation, which generated few steric clashes with PT in molecular docking. However, this minor effect on PT affinity belied large, offsetting changes to association enthalpy and entropy. The escape mutations had negligible effect on CD4 binding and utilization during entry, but significantly altered both binding thermodynamics and inhibitory potency of the conformationally-specific, anti-CD4i antibody 17b. Moreover, the escape mutations substantially decreased gp120 shedding induced by either soluble CD4 or AAR029b. Conclusions Together, the data suggest that the escape mutations significantly modified the energetic landscape of Env’s prefusogenic state, altering conformational dynamics to hinder PT-induced irreversible inactivation of Env. This work therein reveals a unique mode of virus escape for HIV-1, namely, resistance by altering the intrinsic conformational dynamics of the Env trimer.

• Publisher: BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
• Subject: Acquired immune deficiency syndrome / Affinity / AIDS / Anti-HIV agents / Anti-HIV Agents - chemistry / Anti-HIV Agents - pharmacology / Antibodies / Antifungal agents / Antiviral agents / Antiviral drugs / Binding Sites / Biomedical and Life Sciences / Biomedicine / Cancer Research / CD4 antigen / Disease resistance / Drug dosages / Drug Resistance, Viral / Entropy / Entry inhibitor / Envelope glycoproteins / Glycoprotein gp120 / Glycoprotein gp41 / Glycoproteins / gp120 shedding / HIV / HIV (Viruses) / HIV Envelope Protein gp120 - chemistry / HIV Envelope Protein gp120 - genetics / HIV Envelope Protein gp120 - metabolism / HIV Infections - virology / HIV-1 / HIV-1 - chemistry / HIV-1 - drug effects / HIV-1 - genetics / HIV-1 - metabolism / Human immunodeficiency virus / Humans / Inactivators / Infectious Diseases / Infectivity / Molecular Docking Simulation / Mutation / Peptide inhibitors / Peptides / Peptides - chemistry / Peptides - pharmacology / Propagation / Protein Conformation / Protein Structure / Resistance mechanism / Triazoles / Triazoles - chemistry / Triazoles - pharmacology / Trimers / Vaccine / Virions / Virology / Virus escape / Virus Internalization - drug effects / Viruses